Low Distribution of TIM-3⁺ Cytotoxic Tumor-Infiltrating Lymphocytes Predicts Poor Outcomes in Gastrointestinal Stromal Tumors

Table 1

Clinicopathological characteristics of GIST patients ().

Characteristics		(%)
Age (years)	≤59	162 (54.2%)
	>59	137 (45.8%)
Gender	Male	161 (53.8%)
	Female	138 (46.2%)
Modified NIH criteria	Low risk	117 (39.1%)
	Intermediate risk	47 (15.7%)
	High risk	135 (45.2%)
Tumor size	≤5 cm	133 (44.5%)
	>5 cm	166 (55.5%)
Tumor site	Stomach	167 (55.9%)
	Small bowel	96 (32.1%)
	Colon	7 (2.3%)
	Others	29 (9.7%)
Mitoses per 50 HPFs	≤5	198 (66.2%)
	5-10	44 (14.7%)
	≥10	57 (19.1%)
Tumor bleeding	Yes	53 (17.7%)
	No	246 (82.3%)
Ki67 classification	I	204 (68.2%)
	II	43 (14.4%)
	III	52 (17.4%)
Recurrence state	Yes	63 (21.1%)
	No	236 (78.9%)
Local invasion	Yes	58 (19.4%)
	No	241 (80.6%)

Abbreviations: HPF, high power field.